nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—kidney cancer—Dexamethasone—ankylosing spondylitis	0.23	0.29	CpDpCtD
Esomeprazole—kidney cancer—Betamethasone—ankylosing spondylitis	0.23	0.29	CpDpCtD
Esomeprazole—prostate cancer—Dexamethasone—ankylosing spondylitis	0.166	0.21	CpDpCtD
Esomeprazole—prostate cancer—Betamethasone—ankylosing spondylitis	0.166	0.21	CpDpCtD
Esomeprazole—CYP2C19—Prednisone—ankylosing spondylitis	0.0253	0.206	CbGbCtD
Esomeprazole—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0202	0.165	CbGbCtD
Esomeprazole—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0158	0.129	CbGbCtD
Esomeprazole—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0153	0.125	CbGbCtD
Esomeprazole—CYP3A4—Betamethasone—ankylosing spondylitis	0.0131	0.107	CbGbCtD
Esomeprazole—CYP3A4—Prednisolone—ankylosing spondylitis	0.0129	0.106	CbGbCtD
Esomeprazole—CYP3A4—Prednisone—ankylosing spondylitis	0.0122	0.0998	CbGbCtD
Esomeprazole—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00763	0.0623	CbGbCtD
Esomeprazole—Angioedema—Betamethasone—ankylosing spondylitis	0.000105	0.00124	CcSEcCtD
Esomeprazole—Angioedema—Dexamethasone—ankylosing spondylitis	0.000105	0.00124	CcSEcCtD
Esomeprazole—Stomatitis—Methotrexate—ankylosing spondylitis	0.000105	0.00123	CcSEcCtD
Esomeprazole—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000105	0.00123	CcSEcCtD
Esomeprazole—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000104	0.00123	CcSEcCtD
Esomeprazole—Immune system disorder—Prednisone—ankylosing spondylitis	0.000104	0.00123	CcSEcCtD
Esomeprazole—Malaise—Betamethasone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Malaise—Dexamethasone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Vertigo—Betamethasone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Vertigo—Dexamethasone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000104	0.00122	CcSEcCtD
Esomeprazole—Infection—Triamcinolone—ankylosing spondylitis	0.000103	0.00121	CcSEcCtD
Esomeprazole—Infection—Methylprednisolone—ankylosing spondylitis	0.000103	0.00121	CcSEcCtD
Esomeprazole—Haematuria—Methotrexate—ankylosing spondylitis	0.000103	0.0012	CcSEcCtD
Esomeprazole—Shock—Triamcinolone—ankylosing spondylitis	0.000102	0.0012	CcSEcCtD
Esomeprazole—Insomnia—Prednisolone—ankylosing spondylitis	0.000102	0.0012	CcSEcCtD
Esomeprazole—Alopecia—Prednisone—ankylosing spondylitis	0.000102	0.0012	CcSEcCtD
Esomeprazole—Shock—Methylprednisolone—ankylosing spondylitis	0.000102	0.0012	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000102	0.00119	CcSEcCtD
Esomeprazole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000102	0.00119	CcSEcCtD
Esomeprazole—Epistaxis—Methotrexate—ankylosing spondylitis	0.000101	0.00119	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000101	0.00119	CcSEcCtD
Esomeprazole—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000101	0.00119	CcSEcCtD
Esomeprazole—Mental disorder—Prednisone—ankylosing spondylitis	0.000101	0.00119	CcSEcCtD
Esomeprazole—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000101	0.00119	CcSEcCtD
Esomeprazole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000101	0.00118	CcSEcCtD
Esomeprazole—Malnutrition—Prednisone—ankylosing spondylitis	0.000101	0.00118	CcSEcCtD
Esomeprazole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0001	0.00118	CcSEcCtD
Esomeprazole—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0001	0.00118	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0001	0.00118	CcSEcCtD
Esomeprazole—Hypertension—Dexamethasone—ankylosing spondylitis	9.97e-05	0.00117	CcSEcCtD
Esomeprazole—Hypertension—Betamethasone—ankylosing spondylitis	9.97e-05	0.00117	CcSEcCtD
Esomeprazole—Myalgia—Dexamethasone—ankylosing spondylitis	9.83e-05	0.00115	CcSEcCtD
Esomeprazole—Myalgia—Betamethasone—ankylosing spondylitis	9.83e-05	0.00115	CcSEcCtD
Esomeprazole—Anxiety—Betamethasone—ankylosing spondylitis	9.79e-05	0.00115	CcSEcCtD
Esomeprazole—Anxiety—Dexamethasone—ankylosing spondylitis	9.79e-05	0.00115	CcSEcCtD
Esomeprazole—Discomfort—Betamethasone—ankylosing spondylitis	9.71e-05	0.00114	CcSEcCtD
Esomeprazole—Discomfort—Dexamethasone—ankylosing spondylitis	9.71e-05	0.00114	CcSEcCtD
Esomeprazole—Pain—Prednisolone—ankylosing spondylitis	9.66e-05	0.00113	CcSEcCtD
Esomeprazole—Hepatitis—Methotrexate—ankylosing spondylitis	9.65e-05	0.00113	CcSEcCtD
Esomeprazole—Pharyngitis—Methotrexate—ankylosing spondylitis	9.58e-05	0.00113	CcSEcCtD
Esomeprazole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	9.53e-05	0.00112	CcSEcCtD
Esomeprazole—Vision blurred—Prednisone—ankylosing spondylitis	9.48e-05	0.00111	CcSEcCtD
Esomeprazole—Urethral disorder—Methotrexate—ankylosing spondylitis	9.46e-05	0.00111	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	9.46e-05	0.00111	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	9.44e-05	0.00111	CcSEcCtD
Esomeprazole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.42e-05	0.00111	CcSEcCtD
Esomeprazole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.42e-05	0.00111	CcSEcCtD
Esomeprazole—Insomnia—Triamcinolone—ankylosing spondylitis	9.39e-05	0.0011	CcSEcCtD
Esomeprazole—Insomnia—Methylprednisolone—ankylosing spondylitis	9.37e-05	0.0011	CcSEcCtD
Esomeprazole—Infection—Betamethasone—ankylosing spondylitis	9.36e-05	0.0011	CcSEcCtD
Esomeprazole—Infection—Dexamethasone—ankylosing spondylitis	9.36e-05	0.0011	CcSEcCtD
Esomeprazole—Ill-defined disorder—Prednisone—ankylosing spondylitis	9.33e-05	0.0011	CcSEcCtD
Esomeprazole—Paraesthesia—Triamcinolone—ankylosing spondylitis	9.32e-05	0.0011	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.31e-05	0.00109	CcSEcCtD
Esomeprazole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	9.3e-05	0.00109	CcSEcCtD
Esomeprazole—Visual impairment—Methotrexate—ankylosing spondylitis	9.3e-05	0.00109	CcSEcCtD
Esomeprazole—Anaemia—Prednisone—ankylosing spondylitis	9.29e-05	0.00109	CcSEcCtD
Esomeprazole—Shock—Dexamethasone—ankylosing spondylitis	9.27e-05	0.00109	CcSEcCtD
Esomeprazole—Shock—Betamethasone—ankylosing spondylitis	9.27e-05	0.00109	CcSEcCtD
Esomeprazole—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.26e-05	0.00109	CcSEcCtD
Esomeprazole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	9.24e-05	0.00109	CcSEcCtD
Esomeprazole—Nervous system disorder—Betamethasone—ankylosing spondylitis	9.24e-05	0.00109	CcSEcCtD
Esomeprazole—Agitation—Prednisone—ankylosing spondylitis	9.24e-05	0.00109	CcSEcCtD
Esomeprazole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9.23e-05	0.00108	CcSEcCtD
Esomeprazole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9.23e-05	0.00108	CcSEcCtD
Esomeprazole—Tachycardia—Betamethasone—ankylosing spondylitis	9.2e-05	0.00108	CcSEcCtD
Esomeprazole—Tachycardia—Dexamethasone—ankylosing spondylitis	9.2e-05	0.00108	CcSEcCtD
Esomeprazole—Angioedema—Prednisone—ankylosing spondylitis	9.19e-05	0.00108	CcSEcCtD
Esomeprazole—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.14e-05	0.00107	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—ankylosing spondylitis	9.13e-05	0.00107	CcSEcCtD
Esomeprazole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.12e-05	0.00107	CcSEcCtD
Esomeprazole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	9.11e-05	0.00107	CcSEcCtD
Esomeprazole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	9.11e-05	0.00107	CcSEcCtD
Esomeprazole—Malaise—Prednisone—ankylosing spondylitis	9.07e-05	0.00106	CcSEcCtD
Esomeprazole—Vertigo—Prednisone—ankylosing spondylitis	9.03e-05	0.00106	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—ankylosing spondylitis	9.02e-05	0.00106	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—ankylosing spondylitis	9e-05	0.00106	CcSEcCtD
Esomeprazole—Anorexia—Betamethasone—ankylosing spondylitis	8.98e-05	0.00105	CcSEcCtD
Esomeprazole—Anorexia—Dexamethasone—ankylosing spondylitis	8.98e-05	0.00105	CcSEcCtD
Esomeprazole—Urticaria—Prednisolone—ankylosing spondylitis	8.97e-05	0.00105	CcSEcCtD
Esomeprazole—Fatigue—Triamcinolone—ankylosing spondylitis	8.95e-05	0.00105	CcSEcCtD
Esomeprazole—Fatigue—Methylprednisolone—ankylosing spondylitis	8.93e-05	0.00105	CcSEcCtD
Esomeprazole—Pain—Triamcinolone—ankylosing spondylitis	8.88e-05	0.00104	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—ankylosing spondylitis	8.72e-05	0.00102	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	8.7e-05	0.00102	CcSEcCtD
Esomeprazole—Hypertension—Prednisone—ankylosing spondylitis	8.68e-05	0.00102	CcSEcCtD
Esomeprazole—Chills—Methotrexate—ankylosing spondylitis	8.66e-05	0.00102	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	8.58e-05	0.00101	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	8.58e-05	0.00101	CcSEcCtD
Esomeprazole—Myalgia—Prednisone—ankylosing spondylitis	8.56e-05	0.00101	CcSEcCtD
Esomeprazole—Arthralgia—Prednisone—ankylosing spondylitis	8.56e-05	0.00101	CcSEcCtD
Esomeprazole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.56e-05	0.001	CcSEcCtD
Esomeprazole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.54e-05	0.001	CcSEcCtD
Esomeprazole—Anxiety—Prednisone—ankylosing spondylitis	8.53e-05	0.001	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—ankylosing spondylitis	8.53e-05	0.001	CcSEcCtD
Esomeprazole—Insomnia—Betamethasone—ankylosing spondylitis	8.52e-05	0.001	CcSEcCtD
Esomeprazole—Insomnia—Dexamethasone—ankylosing spondylitis	8.52e-05	0.001	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	8.5e-05	0.000998	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	8.47e-05	0.000995	CcSEcCtD
Esomeprazole—Paraesthesia—Dexamethasone—ankylosing spondylitis	8.46e-05	0.000994	CcSEcCtD
Esomeprazole—Paraesthesia—Betamethasone—ankylosing spondylitis	8.46e-05	0.000994	CcSEcCtD
Esomeprazole—Discomfort—Prednisone—ankylosing spondylitis	8.46e-05	0.000993	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—ankylosing spondylitis	8.46e-05	0.000993	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—ankylosing spondylitis	8.4e-05	0.000987	CcSEcCtD
Esomeprazole—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.32e-05	0.000977	CcSEcCtD
Esomeprazole—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.29e-05	0.000974	CcSEcCtD
Esomeprazole—Dyspepsia—Betamethasone—ankylosing spondylitis	8.29e-05	0.000974	CcSEcCtD
Esomeprazole—Urticaria—Triamcinolone—ankylosing spondylitis	8.25e-05	0.000969	CcSEcCtD
Esomeprazole—Urticaria—Methylprednisolone—ankylosing spondylitis	8.23e-05	0.000967	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—ankylosing spondylitis	8.23e-05	0.000966	CcSEcCtD
Esomeprazole—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.21e-05	0.000964	CcSEcCtD
Esomeprazole—Anaphylactic shock—Prednisone—ankylosing spondylitis	8.21e-05	0.000964	CcSEcCtD
Esomeprazole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.19e-05	0.000962	CcSEcCtD
Esomeprazole—Decreased appetite—Betamethasone—ankylosing spondylitis	8.19e-05	0.000962	CcSEcCtD
Esomeprazole—Decreased appetite—Dexamethasone—ankylosing spondylitis	8.19e-05	0.000962	CcSEcCtD
Esomeprazole—Infection—Prednisone—ankylosing spondylitis	8.15e-05	0.000957	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	8.13e-05	0.000955	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	8.13e-05	0.000955	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—ankylosing spondylitis	8.13e-05	0.000954	CcSEcCtD
Esomeprazole—Fatigue—Betamethasone—ankylosing spondylitis	8.12e-05	0.000954	CcSEcCtD
Esomeprazole—Fatigue—Dexamethasone—ankylosing spondylitis	8.12e-05	0.000954	CcSEcCtD
Esomeprazole—Shock—Prednisone—ankylosing spondylitis	8.07e-05	0.000948	CcSEcCtD
Esomeprazole—Pain—Betamethasone—ankylosing spondylitis	8.06e-05	0.000946	CcSEcCtD
Esomeprazole—Pain—Dexamethasone—ankylosing spondylitis	8.06e-05	0.000946	CcSEcCtD
Esomeprazole—Nervous system disorder—Prednisone—ankylosing spondylitis	8.05e-05	0.000945	CcSEcCtD
Esomeprazole—Tachycardia—Prednisone—ankylosing spondylitis	8.01e-05	0.00094	CcSEcCtD
Esomeprazole—Skin disorder—Prednisone—ankylosing spondylitis	7.97e-05	0.000936	CcSEcCtD
Esomeprazole—Hyperhidrosis—Prednisone—ankylosing spondylitis	7.93e-05	0.000932	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—ankylosing spondylitis	7.92e-05	0.00093	CcSEcCtD
Esomeprazole—Anorexia—Prednisone—ankylosing spondylitis	7.82e-05	0.000919	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	7.8e-05	0.000916	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—ankylosing spondylitis	7.77e-05	0.000912	CcSEcCtD
Esomeprazole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.76e-05	0.000912	CcSEcCtD
Esomeprazole—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.76e-05	0.000912	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	7.7e-05	0.000905	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	7.7e-05	0.000905	CcSEcCtD
Esomeprazole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.65e-05	0.000898	CcSEcCtD
Esomeprazole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.63e-05	0.000896	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—ankylosing spondylitis	7.58e-05	0.00089	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—ankylosing spondylitis	7.55e-05	0.000887	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—ankylosing spondylitis	7.52e-05	0.000883	CcSEcCtD
Esomeprazole—Urticaria—Dexamethasone—ankylosing spondylitis	7.49e-05	0.000879	CcSEcCtD
Esomeprazole—Urticaria—Betamethasone—ankylosing spondylitis	7.49e-05	0.000879	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	7.48e-05	0.000878	CcSEcCtD
Esomeprazole—Dizziness—Prednisolone—ankylosing spondylitis	7.47e-05	0.000877	CcSEcCtD
Esomeprazole—Asthenia—Triamcinolone—ankylosing spondylitis	7.45e-05	0.000875	CcSEcCtD
Esomeprazole—Abdominal pain—Betamethasone—ankylosing spondylitis	7.45e-05	0.000875	CcSEcCtD
Esomeprazole—Body temperature increased—Betamethasone—ankylosing spondylitis	7.45e-05	0.000875	CcSEcCtD
Esomeprazole—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.45e-05	0.000875	CcSEcCtD
Esomeprazole—Body temperature increased—Dexamethasone—ankylosing spondylitis	7.45e-05	0.000875	CcSEcCtD
Esomeprazole—Asthenia—Methylprednisolone—ankylosing spondylitis	7.43e-05	0.000873	CcSEcCtD
Esomeprazole—Insomnia—Prednisone—ankylosing spondylitis	7.42e-05	0.000872	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisone—ankylosing spondylitis	7.37e-05	0.000865	CcSEcCtD
Esomeprazole—Pruritus—Triamcinolone—ankylosing spondylitis	7.35e-05	0.000863	CcSEcCtD
Esomeprazole—Cough—Methotrexate—ankylosing spondylitis	7.33e-05	0.000861	CcSEcCtD
Esomeprazole—Pruritus—Methylprednisolone—ankylosing spondylitis	7.33e-05	0.000861	CcSEcCtD
Esomeprazole—Dyspepsia—Prednisone—ankylosing spondylitis	7.22e-05	0.000848	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—ankylosing spondylitis	7.15e-05	0.00084	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—ankylosing spondylitis	7.15e-05	0.00084	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—ankylosing spondylitis	7.15e-05	0.00084	CcSEcCtD
Esomeprazole—Decreased appetite—Prednisone—ankylosing spondylitis	7.13e-05	0.000838	CcSEcCtD
Esomeprazole—Rash—Prednisolone—ankylosing spondylitis	7.12e-05	0.000836	CcSEcCtD
Esomeprazole—Dermatitis—Prednisolone—ankylosing spondylitis	7.11e-05	0.000835	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	7.1e-05	0.000834	CcSEcCtD
Esomeprazole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.09e-05	0.000833	CcSEcCtD
Esomeprazole—Fatigue—Prednisone—ankylosing spondylitis	7.07e-05	0.000831	CcSEcCtD
Esomeprazole—Headache—Prednisolone—ankylosing spondylitis	7.07e-05	0.000831	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—ankylosing spondylitis	7.07e-05	0.00083	CcSEcCtD
Esomeprazole—Constipation—Prednisone—ankylosing spondylitis	7.02e-05	0.000824	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—ankylosing spondylitis	6.91e-05	0.000812	CcSEcCtD
Esomeprazole—Dizziness—Triamcinolone—ankylosing spondylitis	6.87e-05	0.000806	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	6.86e-05	0.000805	CcSEcCtD
Esomeprazole—Dizziness—Methylprednisolone—ankylosing spondylitis	6.85e-05	0.000805	CcSEcCtD
Esomeprazole—Infection—Methotrexate—ankylosing spondylitis	6.81e-05	0.0008	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisone—ankylosing spondylitis	6.76e-05	0.000794	CcSEcCtD
Esomeprazole—Asthenia—Dexamethasone—ankylosing spondylitis	6.76e-05	0.000794	CcSEcCtD
Esomeprazole—Asthenia—Betamethasone—ankylosing spondylitis	6.76e-05	0.000794	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—ankylosing spondylitis	6.73e-05	0.00079	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.71e-05	0.000789	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.71e-05	0.000788	CcSEcCtD
Esomeprazole—Nausea—Prednisolone—ankylosing spondylitis	6.71e-05	0.000788	CcSEcCtD
Esomeprazole—Pruritus—Dexamethasone—ankylosing spondylitis	6.67e-05	0.000783	CcSEcCtD
Esomeprazole—Pruritus—Betamethasone—ankylosing spondylitis	6.67e-05	0.000783	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—ankylosing spondylitis	6.66e-05	0.000782	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.63e-05	0.000779	CcSEcCtD
Esomeprazole—Vomiting—Triamcinolone—ankylosing spondylitis	6.6e-05	0.000775	CcSEcCtD
Esomeprazole—Vomiting—Methylprednisolone—ankylosing spondylitis	6.59e-05	0.000774	CcSEcCtD
Esomeprazole—Rash—Triamcinolone—ankylosing spondylitis	6.55e-05	0.000769	CcSEcCtD
Esomeprazole—Dermatitis—Triamcinolone—ankylosing spondylitis	6.54e-05	0.000768	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—ankylosing spondylitis	6.54e-05	0.000768	CcSEcCtD
Esomeprazole—Rash—Methylprednisolone—ankylosing spondylitis	6.53e-05	0.000767	CcSEcCtD
Esomeprazole—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.53e-05	0.000766	CcSEcCtD
Esomeprazole—Urticaria—Prednisone—ankylosing spondylitis	6.52e-05	0.000766	CcSEcCtD
Esomeprazole—Headache—Triamcinolone—ankylosing spondylitis	6.51e-05	0.000764	CcSEcCtD
Esomeprazole—Headache—Methylprednisolone—ankylosing spondylitis	6.49e-05	0.000762	CcSEcCtD
Esomeprazole—Body temperature increased—Prednisone—ankylosing spondylitis	6.49e-05	0.000762	CcSEcCtD
Esomeprazole—Abdominal pain—Prednisone—ankylosing spondylitis	6.49e-05	0.000762	CcSEcCtD
Esomeprazole—Diarrhoea—Betamethasone—ankylosing spondylitis	6.45e-05	0.000757	CcSEcCtD
Esomeprazole—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.45e-05	0.000757	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.25e-05	0.000734	CcSEcCtD
Esomeprazole—Dizziness—Betamethasone—ankylosing spondylitis	6.23e-05	0.000732	CcSEcCtD
Esomeprazole—Dizziness—Dexamethasone—ankylosing spondylitis	6.23e-05	0.000732	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—ankylosing spondylitis	6.2e-05	0.000728	CcSEcCtD
Esomeprazole—Nausea—Triamcinolone—ankylosing spondylitis	6.17e-05	0.000724	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—ankylosing spondylitis	6.16e-05	0.000723	CcSEcCtD
Esomeprazole—Nausea—Methylprednisolone—ankylosing spondylitis	6.15e-05	0.000723	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—ankylosing spondylitis	6.11e-05	0.000718	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—ankylosing spondylitis	6.1e-05	0.000716	CcSEcCtD
Esomeprazole—Hypersensitivity—Prednisone—ankylosing spondylitis	6.05e-05	0.00071	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—ankylosing spondylitis	6.04e-05	0.000709	CcSEcCtD
Esomeprazole—Vomiting—Betamethasone—ankylosing spondylitis	5.99e-05	0.000704	CcSEcCtD
Esomeprazole—Vomiting—Dexamethasone—ankylosing spondylitis	5.99e-05	0.000704	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—ankylosing spondylitis	5.96e-05	0.0007	CcSEcCtD
Esomeprazole—Rash—Betamethasone—ankylosing spondylitis	5.94e-05	0.000698	CcSEcCtD
Esomeprazole—Rash—Dexamethasone—ankylosing spondylitis	5.94e-05	0.000698	CcSEcCtD
Esomeprazole—Dermatitis—Betamethasone—ankylosing spondylitis	5.94e-05	0.000697	CcSEcCtD
Esomeprazole—Dermatitis—Dexamethasone—ankylosing spondylitis	5.94e-05	0.000697	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	5.92e-05	0.000695	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—ankylosing spondylitis	5.91e-05	0.000694	CcSEcCtD
Esomeprazole—Headache—Betamethasone—ankylosing spondylitis	5.9e-05	0.000693	CcSEcCtD
Esomeprazole—Headache—Dexamethasone—ankylosing spondylitis	5.9e-05	0.000693	CcSEcCtD
Esomeprazole—Asthenia—Prednisone—ankylosing spondylitis	5.89e-05	0.000691	CcSEcCtD
Esomeprazole—Pain—Methotrexate—ankylosing spondylitis	5.86e-05	0.000689	CcSEcCtD
Esomeprazole—Pruritus—Prednisone—ankylosing spondylitis	5.81e-05	0.000682	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.65e-05	0.000664	CcSEcCtD
Esomeprazole—Diarrhoea—Prednisone—ankylosing spondylitis	5.61e-05	0.000659	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.61e-05	0.000659	CcSEcCtD
Esomeprazole—Nausea—Betamethasone—ankylosing spondylitis	5.6e-05	0.000657	CcSEcCtD
Esomeprazole—Nausea—Dexamethasone—ankylosing spondylitis	5.6e-05	0.000657	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—ankylosing spondylitis	5.45e-05	0.00064	CcSEcCtD
Esomeprazole—Dizziness—Prednisone—ankylosing spondylitis	5.43e-05	0.000637	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—ankylosing spondylitis	5.42e-05	0.000637	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—ankylosing spondylitis	5.42e-05	0.000637	CcSEcCtD
Esomeprazole—Vomiting—Prednisone—ankylosing spondylitis	5.22e-05	0.000613	CcSEcCtD
Esomeprazole—Rash—Prednisone—ankylosing spondylitis	5.17e-05	0.000608	CcSEcCtD
Esomeprazole—Dermatitis—Prednisone—ankylosing spondylitis	5.17e-05	0.000607	CcSEcCtD
Esomeprazole—Headache—Prednisone—ankylosing spondylitis	5.14e-05	0.000604	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.05e-05	0.000593	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—ankylosing spondylitis	4.92e-05	0.000578	CcSEcCtD
Esomeprazole—Nausea—Prednisone—ankylosing spondylitis	4.87e-05	0.000572	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—ankylosing spondylitis	4.85e-05	0.00057	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—ankylosing spondylitis	4.69e-05	0.000551	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—ankylosing spondylitis	4.53e-05	0.000533	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—ankylosing spondylitis	4.36e-05	0.000512	CcSEcCtD
Esomeprazole—Rash—Methotrexate—ankylosing spondylitis	4.32e-05	0.000508	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—ankylosing spondylitis	4.32e-05	0.000507	CcSEcCtD
Esomeprazole—Headache—Methotrexate—ankylosing spondylitis	4.3e-05	0.000505	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—ankylosing spondylitis	4.07e-05	0.000478	CcSEcCtD
